Efficacy and Safety of IBI303 in Adult Patients With Active Ankylosing Spondylitis (Q66083318)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and Safety of IBI303 in Adult Patients With Active Ankylosing Spondylitis |
clinical trial |
Statements
A Multicenter, Randomized, Double-blind, Parallel-controlled Phase 3 Study Evaluating the Efficacy and Safety of Recombinant Human Monoclonal Antibody Against Human Tumor Necrosis Factor-α (IBI303) Compared to Adalimumab in Patients With Active Ankylosing Spondylitis (English)
0 references
22 September 2016
0 references
22 January 2018
0 references
438
0 references
18 year
0 references
65 year
0 references